stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - Aligos Therapeutics, Inc. | StockGist | StockGist
Companies
ALGS
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
ALGS
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
Aligos Therapeutics, Inc.
Filed Feb 14, 2025
Accepted Feb 13, 2025, 7:00 PM ET
ALGS
CIK 0001799448
View on SEC.gov
Company Profile
0001172661-25-001230
Beneficial Ownership Report
Passive Investment
Reporting Person
Aligos Therapeutics, Inc.
Person Type
IA
CUSIP: 01626L204
Amendment History
4 filings
SCHEDULE 13G
Original
May 15, 2025
0001172661-25-002361
SCHEDULE 13G/A
Amendment 1
Feb 12, 2025
0000902664-25-000862
SCHEDULE 13G/A
Amendment 2
Viewing
Feb 14, 2025
0001172661-25-001230
SCHEDULE 13G/A
Amendment 3
Latest
May 15, 2025
0000935836-25-000358